Clinical trial
Metformin to Prevent the Metabolic Complications of Olanzapine
NCT00682448 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metformin to Prevent the Metabolic Complications of Olanzapine
- Lead sponsor
- Rush University Medical Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2007
- Completion date
- August 31, 2011
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
metabolic complications